top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

33.56 -1.10 (-3.17%)

Streaming Delayed Price Updated: 2:05 PM EDT, Aug 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

3 Small-Cap Stocks We Approach with Caution

August 23, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

Via StockStory

Omnicell President Sells 6,753 Shares ↗

August 20, 2026

Nnamdi Njoku's disposal reduced his direct holdings by 4%, with over half tied to tax withholding from RSU vesting. He retains ~161,223 shares worth $5.81 million.

Via The Motley Fool

Topics Regulatory Compliance

EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination

July 30, 2026

From Omnicell, Inc.

Via Business Wire

Omnicell (NASDAQ:OMCL) Q2 Earnings Beat Overshadowed by Disappointing Guidance ↗

July 30, 2026

Via Chartmill

Topics Earnings

Nvidia, Teradyne, and Omnicell Earnings Set to Test Robotics Sector’s Divergent Momentum ↗

July 23, 2026

Via Chartmill

Beyond the AI Titans: Niche Automation Plays Show Strong Momentum and Earnings Acceleration ↗

July 06, 2026

Via Chartmill

Topics Artificial Intelligence

Omnicell Q2 Earnings Call Highlights ↗

July 30, 2026

Omnicell (NASDAQ:OMCL) reported second-quarter 2026 revenue at the high end of its prior outlook and profitability above expectations, while widening its full-year product bookings range to reflect...

Via MarketBeat

Topics Earnings World Trade

Omnicell (OMCL) Stock Trades Down, Here Is Why

July 30, 2026

What Happened? Shares of healthcare tech company Omnicell (NASDAQ:OMCL) fell 9.9% in the afternoon session after the company issued weak guidance for the upc...

Via StockStory

Topics Artificial Intelligence

Omnicell’s (NASDAQ:OMCL) Q2 CY2026: Beats On Revenue But Stock Drops On Weak Guidance

July 30, 2026

Healthcare tech company Omnicell (NASDAQ:OMCL) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 7.4% year on year to $312.2 million. On th...

Via StockStory

Omnicell Announces Second Quarter 2026 Financial Results

July 30, 2026

From Omnicell, Inc.

Via Business Wire

Omnicell (OMCL) Reports Q2: Everything You Need To Know Ahead Of Earnings

July 28, 2026

Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday morning. Here’s what investors should know. Omnicell beat an...

Via StockStory

2 Cash-Heavy Stocks to Target This Week and 1 We Turn Down

July 22, 2026

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...

Via StockStory

1 Healthcare Stock to Target This Week and 2 We Brush Off

July 20, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...

Via StockStory

Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks

July 15, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare technology ...

Via StockStory

Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026

July 13, 2026

From Omnicell, Inc.

Via Business Wire

Nnamdi Njoku Appointed President of Omnicell

July 01, 2026

From Omnicell, Inc.

Via Business Wire

3 Small-Cap Stocks We’re Skeptical Of

June 30, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

Via StockStory

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

June 19, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

Via StockStory

Q1 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks

June 16, 2026

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology industry, includ...

Via StockStory

1 Profitable Stock with Exciting Potential and 2 That Underwhelm

June 09, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business

June 08, 2026

From Omnicell, Inc.

Via Business Wire

3 Russell 2000 Stocks That Fall Short

June 08, 2026

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...

Via StockStory

Q1 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks

June 04, 2026

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a...

Via StockStory

Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

June 02, 2026

From Omnicell, Inc.

Via Business Wire

3 Healthcare Stocks We Think Twice About

May 29, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...

Via StockStory

A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack

May 25, 2026

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...

Via StockStory

Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch

May 21, 2026

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...

Via StockStory

Spotting Winners: Hims & Hers Health (NYSE:HIMS) And Healthcare Technology Stocks In Q1

May 17, 2026

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Hims & Hers Health (NYSE:HIMS) and its peer...

Via StockStory

3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

May 13, 2026

Omnicell’s 23% return over the past six months has outpaced the S&P 500 by 13%, and its stock price has climbed to $43.73 per share. This was partly due to i...

Via StockStory

Topics Stocks

3 Stocks Under $50 with Warning Signs

May 11, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

220 S. Main St.
Colville, WA 99114

Hours: Mon.-Fri., 8 a.m.-5 p.m.

509-684-4567
editor@statesmanexaminer.com

Site by Amber S. King – Creative Design

Home
About
Contact
Submissions

bottom of page